Following the application of Regulation (EU) 2023/1182 from 1 January 2025 (The date is subject to the relevant written guarantees from the UK being in place.), FMD will be disapplied on packs intended to be supplied in UKNI. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the labelling and packaging of medicinal products for human use following agreement of the Windsor Framework which describes the circumstances in which 2D barcodes and anti tampering devices may continue to be applied to packs intended for sale in the UK (Labelling and packaging of medicinal products for human use following agreement of the Windsor Framework - GOV.UK (www.gov.uk)) after the FMD disapplication date.